LC
PTVE

Lindbrook Capital’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Lindbrook Capital’s Portfolio PTVE Stock Details PTVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$24.7K Buy
1,370
+59
+5% +$1.05K ﹤0.01% 1272
2024
Q4 		$22.9K Hold
1,311
– – ﹤0.01% 1210
2024
Q3 		$15.1K Sell
1,311
-78
-6% -$895 ﹤0.01% 1459
2024
Q2 		$15.7K Buy
1,389
+50
+4% +$665 ﹤0.01% 1384
2024
Q1 		$19.2K Buy
1,339
+3
+0.2% +$43 ﹤0.01% 1237
2023
Q4 		$18.3K Sell
1,336
-470
-26% -$4.95K ﹤0.01% 1224
2023
Q3 		$14.7K Buy
1,806
+536
+42% +$4.38K ﹤0.01% 1215
2023
Q2 		$9.61K Buy
1,270
+1,239
+3,997% +$9.46K ﹤0.01% 1487
2023
Q1 		$248 Buy
31
+16
+107% +$165 ﹤0.01% 2701
2022
Q4 		$170 Sell
15
-137
-90% -$1.5K ﹤0.01% 2752
2022
Q3 		$1K Buy
152
+93
+158% +$966 ﹤0.01% 2541
2022
Q2 		$1K Buy
59
+8
+16% +$81 ﹤0.01% 2419
2022
Q1 		$1K Buy
+51
New +$542 ﹤0.01% 2415

Other funds holding PTVE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lindbrook Capital's PTVE Position: Q1 2025 in Review

Lindbrook Capital increased its Pactiv Evergreen Inc. Common stock (PTVE) stake by 4.5% in Q1 2025, buying an estimated $1.05K and bringing the position to 1,370 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Lindbrook Capital first reported a position in PTVE in Q1 2022 and has held it in 13 quarters since. 163 funds tracked by Wall St. Rank hold PTVE as of Q1 2025.

  • Lindbrook Capital held 1,370 shares of Pactiv Evergreen Inc. Common stock worth $24.7K as of Q1 2025.
  • Lindbrook Capital bought 59 Pactiv Evergreen Inc. Common stock shares in Q1 2025, an estimated $1.05K.
  • Pactiv Evergreen Inc. Common stock made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1272 holding.
  • Lindbrook Capital first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and has held it in 13 quarters since.
  • 163 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.